Bavarian Nordic Completes Enrollment of Phase 3 Lot-Consistency Trial of Freeze-dried Smallpox Vaccine

    NEXT STORY
    Oasmia resolves on a rights issue of approximately SEK 399 million
    PREV STORY
    Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    CORRECTING and REPLACING – Yuhan Corp and Sorrento Therapeutics Announce Completion of Phase 1 Clinical Study of Anti-PD-L1 Antibody IMC-001

    author_avatar
    NASDAQ Market News

    invendo medical Announces CE Mark for the invendoscope™ SC200, The World’s First Sterile, Single-Use Endoscope For Colonoscopies

    NEW YORK and KISSING, Germany, Dec. 05, 2016 (GLOBE NEWSWIRE) -- invendo medical GmbH, ...

    author_avatar
    NASDAQ Market News

    Fate Therapeutics Appoints Chris M. Storgard, M.D. as Chief Medical Officer

    SAN DIEGO, May 17, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News